Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 493 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Parexel acquires Heron Group

The purchase price was approximately $24m in addition to the possibility of $14.2m over twenty-six months if specific financial targets for Heron are achieved. Heron has methodologies spanning

Pfizer Q1 net income increased

Revenues were $13.5bn for the first quarter ended 31 March 2013, a decrease of 9%, compared to $14.88bn for the same quarter of the previous year. Pfizer chairman

GSK seeks FDA approval for COPD monotherapy

The investigational once-daily UMEC, administered using the Ellipta inhaler, is a bronchodilator molecule and a long-acting muscarinic antagonist (LAMA). Application is submitted for the maintenance bronchodilator treatment of